Methylphenidate in Progressive Supranuclear Palsy [PSP] – Old drug, New Indications? - MDS Abstracts
![Progressive Supranuclear Palsy: Diagnostic Considerations and Emerging Treatment Approaches - YouTube Progressive Supranuclear Palsy: Diagnostic Considerations and Emerging Treatment Approaches - YouTube](https://i.ytimg.com/vi/YvpBH5hET50/maxresdefault.jpg)
Progressive Supranuclear Palsy: Diagnostic Considerations and Emerging Treatment Approaches - YouTube
Cortical Thickness, Surface Area and Volume Measures in Parkinson's Disease, Multiple System Atrophy and Progressive Supranuclear Palsy | PLOS ONE
![Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial - The Lancet Neurology Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/7b9e8591-9d35-4f1d-8b89-74f87edf81e5/gr1.jpg)
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial - The Lancet Neurology
![Clinical diagnostic criteria for progressive supranuclear palsy (PSP)... | Download Scientific Diagram Clinical diagnostic criteria for progressive supranuclear palsy (PSP)... | Download Scientific Diagram](https://www.researchgate.net/profile/Michael-Geschwind/publication/318495799/figure/tbl1/AS:771846316253185@1561033910444/Clinical-diagnostic-criteria-for-progressive-supranuclear-palsy-PSP-and-corticobasal_Q640.jpg)